GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progenics Pharmaceuticals Inc (FRA:PGP) » Definitions » FCF Yield %

Progenics Pharmaceuticals (FRA:PGP) FCF Yield % : 0.00 (As of May. 26, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Progenics Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Progenics Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-66.56 Mil, and Market Cap is €316.82 Mil. Therefore, Progenics Pharmaceuticals's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Progenics Pharmaceuticals's FCF Yield % or its related term are showing as below:


FRA:PGP's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -14.53
* Ranked among companies with meaningful FCF Yield % only.

Progenics Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2020 was -178.62%.


Progenics Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Progenics Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progenics Pharmaceuticals FCF Yield % Chart

Progenics Pharmaceuticals Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.31 2.40 -13.40 -14.85 -20.78

Progenics Pharmaceuticals Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.13 -16.92 -17.09 -19.96 -14.22

Competitive Comparison of Progenics Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Progenics Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Progenics Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Progenics Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Progenics Pharmaceuticals's FCF Yield % falls into.



Progenics Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Progenics Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2019 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-80.936 / 389.52
=-20.78%

Progenics Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2020 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-10.099 * 4 / 284.03488
=-14.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Progenics Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Progenics Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Progenics Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Progenics Pharmaceuticals (FRA:PGP) Business Description

Traded in Other Exchanges
N/A
Address
One World Trade Center, Suite J, 47th Floor, New York, NY, USA, 10007
Progenics Pharmaceuticals Inc is an oncology company focused on developing and commercializing targeted medicines and artificial intelligence to treat cancer. Its portfolio includes AZEDRA (to treat malignant and recurrent pheochromocytoma and paraganglioma); 1404 and PyL (imaging agents for prostate cancer); 1404 Index and PyL (analytical tools for analysis and indexing of images for prostate cancer); 1095 (treatment of metastatic prostate cancer); PSMA ADC (treatment of metastatic castration-resistant prostate cancer); and EXINI boneBSI (an analytical Bone Scan Index tool from bone scintigraphy images, currently sold in Europe and Japan). Its partnered products are RELISTOR (sold in the U.S., EU, Australia, and Canada) to treat opioid-induced constipation, and the PRO 140 HIV treatment.

Progenics Pharmaceuticals (FRA:PGP) Headlines

From GuruFocus

PGP Statement on SEC Settlement

By sperokesalga sperokesalga 06-16-2023